Moderna's good news goes bad

Podcast: Wall Street Breakfast · Seeking Alpha

Opublikowano: 2026-10-23

Moderna's (MRNA) cancer vaccine clears a hurdle, but the stock hits a wall. (00:13) Tower stocks (CCI) (AMT) soar as investors size up a major opportunity. (01:29) Kohl's (KSS) gets a rare buy rating. (02:25) Episode transcripts seekingalpha.com/wsb. Show links: Biggest stock movers Friday: SKHY, MRNA, DECK, and more Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.